Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee" [Cancer Treatm. Rev. 107 (2022) 102396]

H Woopen, J Sehouli, A Davis, Y C Lee, P A Cohen, A Ferrero, N Gleeson, A Jhingran, Y Kajimoto, J Mayadev, M P Barretina-Ginesta, S Sundar, N Suzuki, E van Dorst, F Joly

Research output: Contribution to journal › Comment/debate › peer-review

1 Review article

1 results

Filter

2022

GCIG-Consensus Guideline for Long-term survivorship in Gynecologic Cancer: a position paper from the Gynecologic Cancer Intergroup (GCIG) symptom benefit committee
Woopen, H., Sehouli, J., Davis, A., Lee, Y. C., Cohen, P. A., Ferrero, A., Gleeson, N., Jhingran, A., Kajimoto, Y., Mayadev, J., Barretina-Ginesta, M. P., Sundar, S., Suzuki, N., van Dorst, E. & Joly, F., Jun 2022, In: Cancer Treatment Reviews. 107, 102396.
Research output: Contribution to journal › Review article › peer-review

3 Citations (Web of Science)

Erratum to "GCIG-Consensus guideline for long-term survivorship in gynecologic cancer: A position paper from the Gynecologic Cancer InterGroup (GCIG) symptom benefit committee" [Cancer Treatm. Rev. 107 (2022) 102396]

Research output

Search results

GCIG-Consensus Guideline for Long-term survivorship in Gynecologic Cancer: a position paper from the Gynecologic Cancer Intergroup (GCIG) symptom benefit committee